Divi's Laboratories (BOM:532488) Short-Term Debt : ₹50 Mil (As of Sep. 2024)

View and export this data going back to 2003. Start your Free Trial

What is Divi's Laboratories Short-Term Debt?

Divi's Laboratories's Short-Term Debt for the quarter that ended in Sep. 2024 was ₹50 Mil.

Divi's Laboratories's quarterly Short-Term Debt stayed the same from Mar. 2024 (₹0 Mil) to Jun. 2024 (₹0 Mil) but then increased from Jun. 2024 (₹0 Mil) to Sep. 2024 (₹50 Mil).

Divi's Laboratories Short-Term Debt Historical Data

The historical data trend for Divi's Laboratories's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Divi's Laboratories Short-Term Debt Chart

Divi's Laboratories Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Short-Term Debt

Get a 7-Day Free Trial

336.30

3.50

Divi's Laboratories Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Short-Term Debt	Get a 7-Day Free Trial															20.00	-	-	-	50.00

Divi's Laboratories Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Divi's Laboratories Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Divi's Laboratories's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Divi's Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Divi's Laboratories Ltd (BOM:532488) » Definitions » Short-Term Debt

Traded in Other Exchanges

DIVISLAB:India

Address

Cyber Hills, Divi Towers, 1-72/23(P)/DIVIS/303, Gachibowli, Hyderabad, TG, IND, 500032

Website

https://www.divislabs.com

Divi's Laboratories Ltd is a specialty and generic drug manufacturing company. It is engaged in the manufacture of Active Pharmaceutical ingredients (API), Intermediates, and Nutraceutical ingredients with a predominance in exports. It also through its custom synthesis, supports pharma companies for their patented products business from gram scale requirements for clinical trials to launch as well as late life cycle management. Geographically, the company derives a majority of its revenue through exports to countries like the United States of America, Switzerland, and other countries.

Divi's Laboratories Headlines

No Headlines